Potential microRNA panel for the diagnosis and prediction of overall survival of hepatocellular carcinoma with hepatitis B virus infection

被引:0
|
作者
Qi Zhang [1 ]
Hai-Feng Xu [2 ]
Wen-Yue Song [1 ]
Peng-Jun Zhang [2 ]
Yong-Bo Song [1 ]
机构
[1] School of Life Science and Biopharmaceutics,Shenyang Pharmaceutical University
[2] Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing), Interventional Therapy Department, Peking University Cancer Hospital and Institute
基金
国家重点研发计划;
关键词
Hepatitis B virus infection; Hepatocellular carcinoma; MicroRNAs; Cirrhosis; Biomarker; Tissue;
D O I
暂无
中图分类号
R735.7 [肝肿瘤]; R512.62 [];
学科分类号
100214 ; 100401 ;
摘要
BACKGROUND In hepatocellular carcinoma(HCC), abnormal expression of multiple micro RNAs(miRNAs) has been shown to be involved in the malignant biological behavior of liver cancer. The vast majority of liver cancer cases in China are closely related to hepatitis B virus(HBV) infection, but there are few studies on the changes of miRNA expression in the progression from HBV infection to hepatoma.AIM To explore the role of miRNAs in the progression of HBV infection to cirrhosis and even to liver cancer.METHODS We screened differentially expressed miRNAs in 40 HBV cirrhosis, 40 normal and15 HCC tissues by using a Taq Man Low Density Array and real time quantitative polymerase chain reaction. To evaluate the power of the selected miRNAs to predict disease, we calculated the area under the receiver-operating-characteristic curves. The overall survival of HBV cirrhosis patients was analyzed via KaplanMeier analysis.RESULTS The levels of miR-375, miR-122 and miR-143 were significantly lower in HBV cirrhosis tissues, while miR-224 was significantly higher than in the controls(P <0.0001). The area under the curves of the receiver-operating-characteristic curve for the 4-miRNA panel was 0.991(95%CI: 0.974-1). Patients with a lower expression level of miR-224 or higher expression levels of miR-375, miR-122 and miR-143 had longer overall survival.CONCLUSIONThe four miRNAs(miR-375, miR-122, miR-143 and miR-224) may be helpful for early diagnosis of HBV infection, HBV cirrhosis, and prediction of its overall survival.
引用
收藏
页码:383 / 393
页数:11
相关论文
共 50 条
  • [41] Hepatitis B virus and hepatocellular carcinoma
    Tiollais, P
    Pineau, P
    Wei, Y
    Dejean, A
    Buendia, MA
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 1998, 182 (01): : 73 - 78
  • [42] HBsAg-negative Hepatitis B Virus Infection and Hepatocellular Carcinoma
    Chen, Liping
    Zhao, Hong
    Yang, Xiaoqin
    Gao, Jackson Y.
    Cheng, Jilin
    DISCOVERY MEDICINE, 2014, 18 (99) : 189 - 193
  • [43] Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma
    Shoji Kubo
    Shigekazu Takemura
    Shogo Tanaka
    Hiroji Shinkawa
    Takayoshi Nishioka
    Akinori Nozawa
    Masahiko Kinoshita
    Genya Hamano
    Tokuji Ito
    Yorihisa Urata
    World Journal of Gastroenterology, 2015, (27) : 8249 - 8255
  • [44] HEPATITIS-B VIRUS-INFECTION AND PRIMARY HEPATOCELLULAR CARCINOMA
    TABOR, E
    GERETY, RJ
    VOGEL, CL
    BAYLEY, AC
    ANTHONY, PP
    CHAN, CH
    BARKER, LF
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1977, 58 (05): : 1197 - 1200
  • [45] mTOR Signaling: Roles in Hepatitis B Virus Infection and Hepatocellular Carcinoma
    Mei, Ling
    Sun, Huizhen
    Yan, Ying
    Ji, Huimin
    Su, Qian
    Chang, Le
    Wang, Lunan
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2024, 20 (11): : 4178 - 4189
  • [46] Occult hepatitis B virus infection and hepatocellular carcinoma: a systematic review
    Huang, X.
    Hollinger, F. B.
    JOURNAL OF VIRAL HEPATITIS, 2014, 21 (03) : 153 - 162
  • [47] STATINS AND THE RISK OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH HEPATITIS B VIRUS INFECTION
    Tsan, Y.
    Lee, C.
    Wang, J.
    Chen, P.
    VALUE IN HEALTH, 2012, 15 (07) : A602 - A603
  • [48] Hepatocellular Carcinoma: Unraveling the Role of Occult Hepatitis B Virus Infection
    Mattos, Angelo Z.
    Mattos, Angelo A.
    Debes, Jose D.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (02) : 407 - 408
  • [49] Treatment of chronic hepatitis B virus infection and hepatocellular carcinoma prevention
    Soudan, Damien
    Sultanik, Philippe
    Pol, Stanislas
    PRESSE MEDICALE, 2015, 44 (12): : 1251 - 1255
  • [50] Prevention of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection
    Kim, Beom Kyung
    Han, Kwang-Hyub
    Ahn, Sang Hoon
    ONCOLOGY, 2011, 81 : 41 - 49